HealthDay News – The US Preventive Services Task Force (USPSTF) recommends that adults 35 to 70 years of age who are overweight or obese should be screened for prediabetes and type 2 diabetes and preventive measures offered. These recommendations form the basis of a final recommendation, which will be published in the edition of 24./31. August of the Journal of the American Medical Association was published.
Daniel E. Jonas, MD, MPH, of RTI International-University of North Carolina at the Chapel Hill Evidence-Based Practice Center, and colleagues reviewed the evidence for screening for prediabetes and diabetes using data from 89 publications that included 68,882 participants. The researchers observed no significant difference between screening and control groups for all-cause mortality or cause-specific mortality at 10 years in two randomized clinical trials with 25,120 participants. Interventions improved health outcomes for those with recently diagnosed diabetes. In obese and overweight individuals with prediabetes, lifestyle interventions have been associated with a reduction in the incidence of diabetes.
Based on these results, the USPSTF is reasonably certain that screening for prediabetes and type 2 diabetes and offering or referring patients to effective preventive interventions have modest net benefits. Screening for prediabetes and type 2 diabetes is recommended in adults 35 to 70 years of age who are overweight or obese; Preventive measures should be offered or referred to patients with prediabetes (recommendation B).
“Clinics can prevent serious health complications by screening adults who are overweight or obese for prediabetes and diabetes,” said Chien-Wen Tseng, MD, MPH, member of the task force. “With proper screening, diabetes can be detected and treated earlier to improve overall health.”
Final declaration of recommendation
Diabetes general medicine obesity